Skip to search formSkip to main contentSkip to account menu

EMA-CO Regimen

Known as: Etoposide-Methotrexate-Actinomycin-Cyclophosphamide-Oncovin Regimen, EMA/CO Regimen, EMA-CO 
A regimen consisting of etoposide, high-dose methotrexate and dactinomycin (Actinomycin-D), followed by cyclophosphamide and vincristine, used for… 
National Institutes of Health

Related topics

Related topics

8 relations

Broader (6)

Antineoplastic Combined Chemotherapy ProtocolsCyclophosphamideDactinomycinEtoposide
Gestational Trophoblastic NeoplasmsVincristine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Excellence in Family Paediatricians: the FIMP-MCRN (Medicines for Children Research Network) becomes a member of ENPR-EMA (European Network of Paediatric Research at the European Medicines Agency)
One of the objectives of the Paediatric Regulation (EC) No 1901/2006, is to foster high quality ethical research on medicinal… 
2010
2010
Metastatic gestational trophoblastic neoplasia complicated by tumor lysis syndrome, heart failure, and thyrotoxicosis: a case report.
BACKGROUND Tumor lysis syndrome (TLS) is an extremely rare complication of solid tumors and is more frequently observed in… 
2010
2010
High-risk gestational trophoblastic neoplasia at Gujarat Cancer and Research Institute: thirteen years of experience.
OBJECTIVE To evaluate and analyze the results of chemotherapy (EMA-CO [etoposide, methotrexate, actinomycin D-cyclophosphamide… 
2010
2010
Management of drug resistant gestational trophoblastic neoplasia.
OBJECTIVE To determine the outcome of secondary management in drug-resistant gestational trophoblastic neoplasia (GTN). STUDY… 
2004
2004
Management of patients with metastatic gestational trophoblastic tumor.
2004
2004
EMA‐EP regimen, as firstline multiple agent chemotherapy in high‐risk GTT patients (stage II–IV)
Multiple agent chemotherapy in high-risk metastatic gestational trophoblastic tumor patients is a problem for any medical team… 
1995
1995
Significance of epithelial membrane antigen in the work‐up of problematic serous effusions
Differentiation of reactive and/or atypical mesothelial cells from malignant epithelial cells in serous effusions remains a… 
1992
1992
Inconsistency of the immunophenotype of Reed-Sternberg cells in simultaneous and consecutive specimens from the same patients. A paraffin section evaluation in 56 patients.
Both immunophenotypic overlaps between Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL), and evolution of one into the… 
1991
1991
High-risk metastatic gestational trophoblastic disease. A new dose-intensive, multiagent chemotherapeutic regimen.
Dose-intensive, multiagent chemotherapy for the treatment of high-risk gestational trophoblastic disease has evolved as the… 
1973
1973
Immobilized enzymes. Synthesis of a new type of polyanionic and polycationic resins and their utilization for the preparation of water-insoluble enzyme derivatives.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)